Related Articles
Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness
Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
PARP1-siRNA suppresses human prostate cancer cell growth and progression